K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 323.15 INR -0.46% Market Closed
Market Cap: 5.2B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Kilitch Drugs (India) Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kilitch Drugs (India) Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Other Current Liabilities
â‚ą72.3m
CAGR 3-Years
10%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Other Current Liabilities
â‚ą57.8B
CAGR 3-Years
15%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Other Current Liabilities
â‚ą25.4B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
17%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Other Current Liabilities
â‚ą93.2B
CAGR 3-Years
-1%
CAGR 5-Years
10%
CAGR 10-Years
15%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Other Current Liabilities
â‚ą10.1B
CAGR 3-Years
7%
CAGR 5-Years
12%
CAGR 10-Years
7%
M
Mankind Pharma Ltd
NSE:MANKIND
Other Current Liabilities
â‚ą8.4B
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kilitch Drugs (India) Ltd
Glance View

Market Cap
5.2B INR
Industry
Pharmaceuticals

Kilitch Drugs (India) Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra. The company is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products include parenteral solutions, effervescent, nutritional products, and medical device. Its products categories include urinary alkalizer, cephalosporins products, gastroenterology, non steroidal anti-inflammatory drugs (NSAIDs), anticonvulsant/antiepileptic, adrenergic agonist, neurotonic, muscle relaxant/stimulant, aminoglycosides, anti-infective, anti-inflammatory, anti-malarials, anti-hypertensive, anaesthetic, uterine stimulants. Its parenteral solutions include neurotonic, veterinary products, metered nasal drops, vaccines, oncology, and ophthalmic products. Its effervescent products include Roipar, Duregra, And Roivit. The firm offers nutritional products, such as Celtine. The firm also offers medical devices, such as C-Seal.

KILITCH Intrinsic Value
251.63 INR
Overvaluation 22%
Intrinsic Value
Price
K

See Also

What is Kilitch Drugs (India) Ltd's Other Current Liabilities?
Other Current Liabilities
72.3m INR

Based on the financial report for Sep 30, 2024, Kilitch Drugs (India) Ltd's Other Current Liabilities amounts to 72.3m INR.

What is Kilitch Drugs (India) Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-1%

Over the last year, the Other Current Liabilities growth was 13%. The average annual Other Current Liabilities growth rates for Kilitch Drugs (India) Ltd have been 10% over the past three years , -1% over the past five years .

Back to Top